Gyre Therapeutics, Inc. Other Nonoperating Income (Expense)
Gyre Therapeutics, Inc. (GYRE) reported Other Nonoperating Income (Expense) of -$943.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-07
- Gyre Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$943.00K.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $29.00K, a 72.90% decline year-over-year.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$2.19M.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $727.00K.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for fiscal 2025 was -$1.50M.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for fiscal 2024 was -$1.66M.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for fiscal 2023 was -$1.52M.
- Gyre Therapeutics, Inc. other nonoperating income (expense) for fiscal 2021 was -$78.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$943.00K 10-Q · filed 2026-08-07 | -$830.00K 10-Q · filed 2026-08-07 | -$3.11M derived: sum of 3 quarters · filed 2026-08-07 | -$2.38M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $29.00K 10-Q · filed 2026-05-08 | -$2.17M derived: sum of 2 quarters · filed 2026-05-08 | -$1.44M derived: sum of 3 quarters · filed 2026-05-08 | -$1.93M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.47M derived: sum of 2 quarters · filed 2026-03-13 | -$1.96M derived: sum of 3 quarters · filed 2026-08-07 | -$1.50M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $727.00K 10-Q · filed 2025-11-07 | $239.00K derived: sum of 2 quarters · filed 2026-08-07 | $689.00K 10-Q · filed 2025-11-07 | -$1.29M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$488.00K 10-Q · filed 2026-08-07 | -$145.00K 10-Q · filed 2025-08-11 | -$301.00K 10-Q · filed 2026-08-07 | -$38.00K 10-Q · filed 2025-08-11 | -$2.02M derived: sum of 3 quarters · filed 2026-08-07 | -$2.09M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $107.00K 10-Q · filed 2026-05-08 | -$1.53M derived: sum of 2 quarters · filed 2026-05-08 | -$1.60M derived: sum of 3 quarters · filed 2026-05-08 | -$1.67M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.71M derived: sum of 2 quarters · filed 2026-03-13 | -$1.78M derived: sum of 3 quarters · filed 2026-03-13 | -$1.66M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$75.00K 10-Q · filed 2025-11-07 | -$598.00K 10-Q · filed 2024-11-13 | -$147.00K derived: sum of 2 quarters · filed 2025-11-07 | -$25.00K 10-Q · filed 2025-11-07 | -$1.23M 10-Q · filed 2024-11-13 | -$262.00K derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | -$72.00K 10-Q · filed 2025-08-11 | -$422.00K 10-Q · filed 2024-08-13 | $50.00K 10-Q · filed 2025-08-11 | -$628.00K 10-Q · filed 2024-08-13 | -$187.00K derived: sum of 3 quarters · filed 2025-08-11 | -$1.52M derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $122.00K 10-Q · filed 2025-05-09 | -$115.00K derived: sum of 2 quarters · filed 2025-05-09 | -$1.45M derived: sum of 3 quarters · filed 2025-05-09 | -$819.00K derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$1.57M derived: sum of 2 quarters · filed 2025-03-17 | -$941.00K derived: sum of 3 quarters · filed 2025-03-17 | -$1.52M 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | -$1.33M 10-Q · filed 2024-11-13 | -$704.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.28M 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | $629.00K 10-Q · filed 2024-08-13 | $52.00K 10-Q · filed 2024-08-13 | ||||||
| 2022-09-30 | -$1.00K 10-Q · filed 2022-11-14 | $16.00K derived: sum of 2 quarters · filed 2022-11-14 | -$1.00K 10-Q · filed 2022-11-14 | -$21.00K derived: sum of 4 quarters · filed 2023-03-30 | ||||
| 2022-06-30 | $17.00K 10-Q · filed 2022-08-15 | $0.00 derived: sum of 2 quarters · filed 2022-08-15 | -$20.00K derived: sum of 3 quarters · filed 2023-03-30 | -$36.00K derived: sum of 4 quarters · filed 2023-03-30 | ||||
| 2022-03-31 | -$17.00K 10-Q · filed 2022-05-09 | -$37.00K derived: sum of 2 quarters · filed 2023-03-30 | -$53.00K derived: sum of 3 quarters · filed 2023-03-30 | -$78.00K derived: sum of 4 quarters · filed 2023-03-30 | ||||
| 2021-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$36.00K derived: sum of 2 quarters · filed 2023-03-30 | -$61.00K derived: sum of 3 quarters · filed 2023-03-30 | -$78.00K 10-K · filed 2023-03-30 | -$87.00K 10-K · filed 2022-03-31 | |||
| 2021-09-30 | -$16.00K 10-Q · filed 2022-11-14 | -$13.00K 10-Q · filed 2021-11-12 | -$41.00K derived: sum of 2 quarters · filed 2022-11-14 | -$58.00K 10-Q · filed 2022-11-14 | -$66.00K 10-Q · filed 2021-11-12 | -$129.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$25.00K 10-Q · filed 2022-08-15 | $27.00K 10-Q · filed 2021-08-05 | -$42.00K 10-Q · filed 2022-08-15 | $53.00K 10-Q · filed 2021-08-05 | -$113.00K derived: sum of 3 quarters · filed 2022-08-15 | -$120.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$17.00K 10-Q · filed 2022-05-09 | -$26.00K 10-Q · filed 2021-05-06 | -$88.00K derived: sum of 2 quarters · filed 2022-05-09 | -$95.00K derived: sum of 3 quarters · filed 2022-05-09 | -$80.00K derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$78.00K derived: sum of 2 quarters · filed 2022-03-31 | -$63.00K derived: sum of 3 quarters · filed 2022-03-31 | -$91.00K 10-K · filed 2022-03-31 | $659.00K 10-K · filed 2021-03-04 | |||
| 2020-09-30 | -$7.00K 10-Q · filed 2021-11-12 | $8.00K derived: sum of 2 quarters · filed 2021-11-12 | -$20.00K 10-Q · filed 2021-11-12 | $12.00K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $15.00K 10-Q · filed 2021-08-05 | $13.00K 10-Q · filed 2021-08-05 | $679.00K 10-Q · filed 2020-08-06 | $19.00K derived: sum of 3 quarters · filed 2021-08-05 | $8.00K derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-06 | $679.00K 10-Q · filed 2020-05-11 | $4.00K derived: sum of 2 quarters · filed 2021-05-06 | -$7.00K derived: sum of 3 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$9.00K derived: sum of 2 quarters · filed 2021-03-04 | -$39.00K 10-K · filed 2021-03-04 | |||||
| 2019-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$41.00K 10-Q · filed 2019-11-07 | ||||||
| 2019-06-30 | -$30.00K 10-Q · filed 2019-08-01 | |||||||
| 2018-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $152.00K derived: sum of 2 quarters · filed 2020-02-20 | $182.00K derived: sum of 3 quarters · filed 2020-02-20 | $1.65M 10-K · filed 2020-02-20 | ||||
| 2018-09-30 | -$1.00K 10-Q · filed 2019-11-07 | $29.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.50M 10-Q · filed 2019-11-07 | $1.31M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $30.00K 10-Q · filed 2019-08-01 | $1.50M 10-Q · filed 2019-08-01 | $1.31M derived: sum of 3 quarters · filed 2019-08-01 | $1.40M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2018-03-31 | $1.47M 10-Q · filed 2019-05-02 | $1.28M derived: sum of 2 quarters · filed 2019-05-02 | $1.37M derived: sum of 3 quarters · filed 2019-05-02 | $1.38M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | -$186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$101.00K derived: sum of 2 quarters · filed 2019-03-08 | -$87.00K derived: sum of 3 quarters · filed 2019-03-08 | -$1.00K 10-K · filed 2019-03-08 | $261.00K 10-K · filed 2018-03-19 | |||
| 2017-09-30 | $85.00K 10-Q · filed 2017-11-02 | $99.00K derived: sum of 2 quarters · filed 2018-08-02 | $185.00K 10-Q · filed 2017-11-02 | $38.00K derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-06-30 | $14.00K 10-Q · filed 2018-08-02 | $67.00K 10-Q · filed 2017-08-03 | $31.00K 10-Q · filed 2018-08-02 | $101.00K 10-Q · filed 2017-08-03 | -$47.00K derived: sum of 3 quarters · filed 2018-08-02 | -$9.00K derived: sum of 4 quarters · filed 2018-08-02 | ||
| 2017-03-31 | $16.00K 10-Q · filed 2018-05-03 | $33.00K 10-Q · filed 2017-05-11 | -$61.00K derived: sum of 2 quarters · filed 2018-05-03 | -$23.00K derived: sum of 3 quarters · filed 2018-05-03 | -$7.00K derived: sum of 4 quarters · filed 2018-05-03 | |||
| 2016-12-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$39.00K derived: sum of 2 quarters · filed 2018-03-19 | -$23.00K derived: sum of 3 quarters · filed 2018-03-19 | $86.00K 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $38.00K 10-Q · filed 2017-11-02 | $54.00K derived: sum of 2 quarters · filed 2017-11-02 | $163.00K 10-Q · filed 2017-11-02 | -$19.00K derived: sum of 4 quarters · filed 2017-11-02 | ||||
| 2016-06-30 | $16.00K 10-Q · filed 2017-08-03 | $35.00K 10-Q · filed 2017-08-03 | -$57.00K derived: sum of 3 quarters · filed 2017-08-03 | -$524.00K derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-03-31 | $20.00K 10-Q · filed 2017-05-11 | -$73.00K derived: sum of 2 quarters · filed 2017-05-11 | -$540.00K derived: sum of 3 quarters · filed 2017-05-11 | |||||
| 2015-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$560.00K derived: sum of 2 quarters · filed 2017-03-08 | $131.00K 10-K · filed 2017-03-08 | |||||
| 2015-09-30 | -$467.00K 10-Q · filed 2016-11-03 | $224.00K 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |